OspF directly attenuates the activity of extracellular signal-regulated kinase during invasion by Shigella flexneri in human dendritic cells

Molecular Immunology

Volumn 45, Issue 11, 2008, Pages 3295-3301

  Kim, Dong Wook ^e   Chu, Hyuk ^c   Joo, Dong Hyun ^a   Jang, Mi Seon ^a   Choi, Jin Huk ^a   Park, Sung Moo ^e   Choi, Yun Jae ^a   Han, Seung Hyun ^d   Yun, Cheol Heui ^a,b  

^a Seoul National University   (South Korea)

^b Seoul National University   (South Korea)

^c Korea National Institute of Health   (South Korea)

^d Seoul National University   (South Korea)

^e International Vaccine Institute   (South Korea)

Author keywords

Dendritic cells; Extracellular signal regulated kinases; OspF; Shigella

Indexed keywords

LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OUTER MEMBRANE PROTEIN; PROTEIN ANTIBODY; PROTIEN OSPF;

APOPTOSIS; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; CELL FUNCTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MONOCYTE; NONHUMAN; PHAGOSOME; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SHIGELLA FLEXNERI; UPREGULATION;

APOPTOSIS; BACTERIAL PROTEINS; CELL LINE; CELL NUCLEUS; DENDRITIC CELLS; HUMANS; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN TRANSPORT; SHIGELLA FLEXNERI;

NEGIBACTERIA; SHIGELLA; SHIGELLA FLEXNERI;

EID: 43649102997     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.02.013     Document Type: Article

References (28)

1. Arbibe L., Kim D.W., Batsche E., Pedron T., Mateescu B., Muchardt C., Parsot C., and Sansonetti P.J. An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses. Nat. Immunol. 8 (2007) 47-56
2. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
3. Bhavsar A.P., Guttman J.A., and Finlay B.B. Manipulation of host-cell pathways by bacterial pathogens. Nature 449 (2007) 827-834
4. Buchrieser C., Glaser P., Rusniok C., Nedjari H., D'Hauteville H., Kunst F., Sansonetti P., and Parsot C. The virulence plasmid pWR100 and the repertoire of proteins secreted by the type III secretion apparatus of Shigella flexneri. Mol. Microbiol. 38 (2000) 760-771
5. Edgeworth J.D., Spencer J., Phalipon A., Griffin G.E., and Sansonetti P.J. Cytotoxicity and interleukin-1beta processing following Shigella flexneri infection of human monocyte-derived dendritic cells. Eur. J. Immunol. 32 (2002) 1464-1471
6. Fernandez-Prada C.M., Hoover D.L., Tall B.D., and Venkatesan M.M. Human monocyte-derived macrophages infected with virulent Shigella flexneri in vitro undergo a rapid cytolytic event similar to oncosis but not apoptosis. Infect. Immun. 65 (1997) 1486-1496
7. Girardin S.E., Boneca I.G., Carneiro L.A., Antignac A., Jehanno M., Viala J., Tedin K., Taha M.K., Labigne A., Zahringer U., Coyle A.J., DiStefano P.S., Bertin J., Sansonetti P.J., and Philpott D.J. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300 (2003) 1584-1587
8. Haimovich B., and Venkatesan M.M. Shigella and Salmonella: death as a means of survival. Microbes Infect. 8 (2006) 568-577
9. Hathaway L.J., Griffin G.E., Sansonetti P.J., and Edgeworth J.D. Human monocytes kill Shigella flexneri but then die by apoptosis associated with suppression of proinflammatory cytokine production. Infect. Immun. 70 (2002) 3833-3842
10. Hilbi H., Moss J.E., Hersh D., Chen Y., Arondel J., Banerjee S., Flavell R.A., Yuan J., Sansonetti P.J., and Zychlinsky A. Shigella-induced apoptosis is dependent on caspase-1 which binds to IpaB. J. Biol. Chem. 273 (1998) 32895-32900
11. Junttila, M.R., Li, S.P., Westermarck, J., 2007. Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. Faseb J. November 26 [Epub ahead of print].
12. Kane C.D., Schuch R., Day Jr. W.A., and Maurelli A.T. MxiE regulates intracellular expression of factors secreted by the Shigella flexneri 2a type III secretion system. J. Bacteriol. 184 (2002) 4409-4419
13. Kim D.W., Lenzen G., Page A.L., Legrain P., Sansonetti P.J., and Parsot C. The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 14046-14051
14. Kohler H., Rodrigues S.P., and McCormick B.A. Shigella flexneri interactions with the basolateral membrane domain of polarized model intestinal epithelium: role of lipopolysaccharide in cell invasion and in activation of the mitogen-activated protein kinase ERK. Infect. Immun. 70 (2002) 1150-1158
15. Kramer R.W., Slagowski N.L., Eze N.A., Giddings K.S., Morrison M.F., Siggers K.A., Starnbach M.N., and Lesser C.F. Yeast functional genomic screens lead to identification of a role for a bacterial effector in innate immunity regulation. PLoS Pathog. 3 (2007) e21
16. Le Gall T., Mavris M., Martino M.C., Bernardini M.L., Denamur E., and Parsot C. Analysis of virulence plasmid gene expression defines three classes of effectors in the type III secretion system of Shigella flexneri. Microbiology 151 (2005) 951-962
17. Li H., Xu H., Zhou Y., Zhang J., Long C., Li S., Chen S., Zhou J.M., and Shao F. The phosphothreonine lyase activity of a bacterial type III effector family. Science 315 (2007) 1000-1003
18. Lucchini S., Liu H., Jin Q., Hinton J.C., and Yu J. Transcriptional adaptation of Shigella flexneri during infection of macrophages and epithelial cells: insights into the strategies of a cytosolic bacterial pathogen. Infect. Immun. 73 (2005) 88-102
19. Mavris M., Sansonetti P.J., and Parsot C. Identification of the cis-acting site involved in activation of promoters regulated by activity of the type III secretion apparatus in Shigella flexneri. J. Bacteriol. 184 (2002) 6751-6759
20. McCoy M.S., Toole J.J., Cunningham J.M., Chang E.H., Lowy D.R., and Weinberg R.A. Characterization of a human colon/lung carcinoma oncogene. Nature 302 (1983) 79-81
21. Niess J.H., and Reinecker H.C. Dendritic cells in the recognition of intestinal microbiota. Cell Microbiol. 8 (2006) 558-564
22. Ogawa M., Handa Y., Ashida H., Suzuki M., and Sasakawa C. The versatility of Shigella effectors. Nat. Rev. Microbiol. 6 (2008) 11-16
23. Okuda J., Toyotome T., Kataoka N., Ohno M., Abe H., Shimura Y., Seyedarabi A., Pickersgill R., and Sasakawa C. Shigella effector IpaH9.8 binds to a splicing factor U2AF(35) to modulate host immune responses. Biochem. Biophys. Res. Commun. 333 (2005) 531-539
24. Parsot C. Shigella spp. and enteroinvasive Escherichia coli pathogenicity factors. FEMS Microbiol. Lett. 252 (2005) 11-18
25. Rohde J.R., Breitkreutz A., Chenal A., Sansonetti P.J., and Parsot C. Type III secretion effectors of the IpaH family are E3 ubiquitin ligases. Cell Host Microbe 1 (2007) 77-83
26. Sansonetti P.J. Rupture, invasion and inflammatory destruction of the intestinal barrier by Shigella, making sense of prokaryote-eukaryote cross-talks. FEMS Microbiol. Rev. 25 (2001) 3-14
27. Sansonetti P.J., Phalipon A., Arondel J., Thirumalai K., Banerjee S., Akira S., Takeda K., and Zychlinsky A. Caspase-1 activation of IL-1beta and IL-18 are essential for Shigella flexneri-induced inflammation. Immunity 12 (2000) 581-590
28. Suzuki T., Nakanishi K., Tsutsui H., Iwai H., Akira S., Inohara N., Chamaillard M., Nunez G., and Sasakawa C. A novel caspase-1/toll-like receptor 4-independent pathway of cell death induced by cytosolic Shigella in infected macrophages. J. Biol. Chem. 280 (2005) 14042-14050